Differential modulation by Delta9-tetrahydrocannabinol (δ9-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 4, 2012, Pages 969-980

  Ngaotepprutaram, Thitirat ^a   Kaplan, Barbara L F ^a   Crawford, Robert B ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

9 THC; Anti CD3 CD28; CB1; CB2; CD40L; Inflammatory diseases; PMA Io

Indexed keywords

CALCIUM IONOPHORE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CD3 ANTIBODY; CD40 LIGAND; DRONABINOL; GLUCOCORTICOID RECEPTOR; LUCIFERASE; MESSENGER RNA; PHORBOL ESTER; CD40 ANTIGEN; PSYCHEDELIC AGENT; TETRAHYDROCANNABINOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CD4+ T LYMPHOCYTE; CELL KINETICS; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE REPRESSION; HORMONE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEADY STATE; SURFACE PROPERTY; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL STRAIN HEK293; CYTOLOGY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; HUMAN; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HALLUCINOGENS; HEK293 CELLS; HUMANS; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SPLEEN; TETRAHYDROCANNABINOL; TRANSFECTION;

EID: 84875841520     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9390-z     Document Type: Article

References (44)

1. Baschant U, Tuckermann J (2010) The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120(2-3):69-75. doi: 10.1016/j.jsbmb.2010.03.058
2. Borner C, Smida M, Hollt V, Schraven B, Kraus J (2009) Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J Biol Chem 284(51):35450-35460
3. Brown AJ (2007) Novel cannabinoid receptors. Br J Pharmacol 152(5):567-575
4. Crist SA, Sprague DL, Ratliff TL (2008) Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes. Blood 111(7):3553-3561
5. Cron RQ (2003) CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 27(2-3):185-202
6. Croxford JL, Yamamura T (2005) Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol 166(1-2):3-18
7. Demuth DG, Molleman A (2006) Cannabinoid signalling. Life Sci 78(6):549-563
8. Eldridge JC, Landfield PW (1990) Cannabinoid interactions with glucocorticoid receptors in rat hippocampus. Brain Res 534(1-2):135-141
9. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229(1):152-172
10. Ford GS, Barnhart B, Shone S, Covey LR (1999) Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol 162(7):4037-4044
11. Fuleihan R, Ramesh N, Horner A, Ahern D, Belshaw PJ, Alberg DG, Stamenkovic I, Harmon W, Geha RS (1994) Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 93(3):1315-1320
12. Kaldjian E, McCarthy SA, Sharrow SO, Littman DR, Klausner RD, Singer A (1988) Nonequivalent effects of PKC activation by PMA on murine CD4 and CD8 cell-surface expression. FASEB J 2(12):2801-2806
13. Kaminski NE (1998) Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds. Toxicol Lett 102-103:59-63
14. Kaplan BL, Rockwell CE, Kaminski NE (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306(3):1077-1085
15. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA (1994) Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 152(12):5643-5652
16. Law CL, Grewal IS (2009) Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 647:8-36
17. Lindgren H, Axcrona K, Leanderson T (2001) Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J Immunol 166(7):4578-4585
18. Lindstein T, June CH, Ledbetter JA, Stella G, Thompson CB (1989) Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244(4902):339-343
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
20. Lobo FM, Zanjani R, Ho N, Chatila TA, Fuleihan RL (1999) Calcium-dependent activation of TNF family gene expression by Ca2+/calmodulin kinase type IV/Gr and calcineurin. J Immunol 162(4):2057-2063
21. Lobo FM, Xu S, Lee C, Fuleihan RL (2000) Transcriptional activity of the distal CD40 ligand promoter. Biochem Biophys Res Commun 279(1):245-250
22. Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE (2009) Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. J Leukoc Biol 85(2):322-329
23. Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5(6):472-484
24. Mackie K (2006) Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46:101-122
25. Makriyannis A, Yang DP, Griffin RG, Das Gupta SK (1990) The perturbation of model membranes by (-)-delta 9-tetrahydrocannabinol. Studies using solid-state 2H- and 13C-NMR. Biochim Biophys Acta 1028(1):31-42
26. Makriyannis A, Tian X, Guo J (2005) How lipophilic cannabinergic ligands reach their receptor sites. Prostaglandins Other Lipid Mediat 77(1-4):210-218
27. Martinez-Valdez H, Madrid-Marina V, Cohen A (2002) Phorbol esters and cAMP differentially regulate the expression of CD4 and CD8 in human thymocytes. BMC Immunol 3:1
28. Newton CA, Chou PJ, Perkins I, Klein TW (2009) CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J Neuroimmune Pharmacol 4(1):92-102
29. Nusslein HG, Frosch KH, Woith W, Lane P, Kalden JR, Manger B (1996) Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur J Immunol 26(4):846-850
30. Pelchen-Matthews A, Parsons IJ, Marsh M (1993) Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J Exp Med 178(4):1209-1222
31. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6(8):635-664
32. Pertwee RG (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17(14):1360-1381
33. Rizvi M, Pathak D, Freedman JE, Chakrabarti S (2008) CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med 14(12):530-538
34. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ (1993) The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151(5):2497-2510
35. Schonbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58(1):4-43
36. Schonbeck U, Mach F, Libby P (2000) CD154 (CD40 ligand). Int J Biochem Cell Biol 32(7):687-693
37. Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE (2008) Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. J Leukoc Biol 84(6):1574-1584
38. Van den Eertwegh AJ, Noelle RJ, Roy M, Shepherd DM, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J Exp Med 178(5):1555-1565
39. van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67(1):2-17
40. Vavassori S, Covey LR (2009) Post-transcriptional regulation in lymphocytes: the case of CD154. RNA Biol 6(3):259-265
41. Vavassori S, Shi Y, Chen CC, Ron Y, Covey LR (2009) In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol 39(8):2224-2232
42. Weyand CM, Goronzy J, Fathman CG (1987) Modulation of CD4 by antigenic activation. J Immunol 138(5):1351-1354
43. Yellin MJ, Sippel K, Inghirami G, Covey LR, Lee JJ, Sinning J, Clark EA, Chess L, Lederman S (1994) CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 152(2):598-608
44. Yokosuka T, Saito T (2010) The immunological synapse, TCR microclusters, and T cell activation. Curr Top Microbiol Immunol 340:81-107